GelSana is pioneering advancements in wound care through its innovative polymer technology, specifically designed to address the challenges associated with chronic wounds. Traditional wound dressings often fail to mitigate inflammation, which is a significant barrier to effective healing. GelSana's proprietary polymers are engineered to reduce inflammation at the wound site, thereby accelerating the healing process. These highly elastic and stretchable dressings conform to various wound shapes and sizes, providing a gentle adherence to healthy tissue while remaining non-adhesive to moist wound beds. This unique property not only facilitates easier dressing changes but also enhances patient comfort.

In addition to their mechanical advantages, GelSana's dressings are capable of sustained drug delivery, which is crucial for treating hard-to-heal wounds such as diabetic ulcers. The hydrogels, exemplified by their first product, Cleragel, are designed to maintain moisture balance by donating moisture to dry wounds and absorbing excess fluids from highly exudative wounds. This dual functionality, combined with the ability to release therapeutics over time, positions GelSana's products as a transformative solution in wound care, aiming to reduce healing times and the associated risks of infection and amputation.

United States

We are a Colorado-based biomaterials company intentionally designing new materials to improve wound healing. Our materials are anti-inflammatory, prevent bacterial adhesion, and are capable of controlled drug delivery.

GelSana

Company Details